vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Natural Grocers by Vitamin Cottage, Inc. (NGVC). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $335.6M, roughly 1.5× Natural Grocers by Vitamin Cottage, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 3.4%, a 3.4% gap on every dollar of revenue. On growth, Natural Grocers by Vitamin Cottage, Inc. posted the faster year-over-year revenue change (1.6% vs -1.7%). Over the past eight quarters, Natural Grocers by Vitamin Cottage, Inc.'s revenue compounded faster (4.4% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Natural Grocers by Vitamin Cottage, Inc. is a U.S.-based specialty retail chain that offers certified organic groceries, dietary supplements, natural personal care items, and eco-friendly household products. It serves health-conscious consumers across multiple U.S. states, following strict quality standards that exclude artificial preservatives, colors, flavors and harmful additives.
MD vs NGVC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $335.6M |
| Net Profit | $33.7M | $11.3M |
| Gross Margin | — | 29.5% |
| Operating Margin | 9.9% | 4.4% |
| Net Margin | 6.8% | 3.4% |
| Revenue YoY | -1.7% | 1.6% |
| Net Profit YoY | 10.5% | 14.0% |
| EPS (diluted) | $0.40 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $335.6M | ||
| Q3 25 | $492.9M | $336.1M | ||
| Q2 25 | $468.8M | $328.7M | ||
| Q1 25 | $458.4M | $335.8M | ||
| Q4 24 | $502.4M | $330.2M | ||
| Q3 24 | $511.2M | $322.7M | ||
| Q2 24 | $504.3M | $309.1M | ||
| Q1 24 | $495.1M | $308.1M |
| Q4 25 | $33.7M | $11.3M | ||
| Q3 25 | $71.7M | $11.8M | ||
| Q2 25 | $39.3M | $11.6M | ||
| Q1 25 | $20.7M | $13.1M | ||
| Q4 24 | $30.5M | $9.9M | ||
| Q3 24 | $19.4M | $9.0M | ||
| Q2 24 | $-153.0M | $9.2M | ||
| Q1 24 | $4.0M | $8.0M |
| Q4 25 | — | 29.5% | ||
| Q3 25 | — | 29.5% | ||
| Q2 25 | — | 29.9% | ||
| Q1 25 | — | 30.3% | ||
| Q4 24 | — | 29.9% | ||
| Q3 24 | — | 29.6% | ||
| Q2 24 | — | 29.2% | ||
| Q1 24 | — | 29.3% |
| Q4 25 | 9.9% | 4.4% | ||
| Q3 25 | 13.8% | 4.6% | ||
| Q2 25 | 12.8% | 4.7% | ||
| Q1 25 | 7.0% | 5.2% | ||
| Q4 24 | 7.8% | 4.0% | ||
| Q3 24 | 6.6% | 3.7% | ||
| Q2 24 | -31.3% | 4.2% | ||
| Q1 24 | 3.2% | 3.7% |
| Q4 25 | 6.8% | 3.4% | ||
| Q3 25 | 14.5% | 3.5% | ||
| Q2 25 | 8.4% | 3.5% | ||
| Q1 25 | 4.5% | 3.9% | ||
| Q4 24 | 6.1% | 3.0% | ||
| Q3 24 | 3.8% | 2.8% | ||
| Q2 24 | -30.3% | 3.0% | ||
| Q1 24 | 0.8% | 2.6% |
| Q4 25 | $0.40 | $0.49 | ||
| Q3 25 | $0.84 | $0.51 | ||
| Q2 25 | $0.46 | $0.50 | ||
| Q1 25 | $0.24 | $0.56 | ||
| Q4 24 | $0.37 | $0.43 | ||
| Q3 24 | $0.23 | $0.38 | ||
| Q2 24 | $-1.84 | $0.40 | ||
| Q1 24 | $0.05 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $23.2M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $220.0M |
| Total Assets | $2.2B | $668.6M |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $23.2M | ||
| Q3 25 | $340.1M | $17.1M | ||
| Q2 25 | $224.7M | $13.2M | ||
| Q1 25 | $99.0M | $21.2M | ||
| Q4 24 | $229.9M | $6.3M | ||
| Q3 24 | $103.8M | $8.9M | ||
| Q2 24 | $19.4M | $13.9M | ||
| Q1 24 | $8.0M | $11.0M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $220.0M | ||
| Q3 25 | $890.7M | $212.4M | ||
| Q2 25 | $833.8M | $202.5M | ||
| Q1 25 | $789.2M | $193.0M | ||
| Q4 24 | $764.9M | $181.9M | ||
| Q3 24 | $732.5M | $174.3M | ||
| Q2 24 | $706.5M | $167.8M | ||
| Q1 24 | $856.2M | $160.0M |
| Q4 25 | $2.2B | $668.6M | ||
| Q3 25 | $2.2B | $670.5M | ||
| Q2 25 | $2.1B | $659.0M | ||
| Q1 25 | $2.0B | $664.6M | ||
| Q4 24 | $2.2B | $648.9M | ||
| Q3 24 | $2.1B | $655.5M | ||
| Q2 24 | $2.0B | $654.4M | ||
| Q1 24 | $2.2B | $656.6M |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $21.1M |
| Free Cash FlowOCF − Capex | — | $11.6M |
| FCF MarginFCF / Revenue | — | 3.4% |
| Capex IntensityCapex / Revenue | — | 2.9% |
| Cash ConversionOCF / Net Profit | 3.39× | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | $42.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $21.1M | ||
| Q3 25 | $137.3M | $15.6M | ||
| Q2 25 | $137.2M | $2.9M | ||
| Q1 25 | $-117.5M | $34.1M | ||
| Q4 24 | $133.0M | $2.7M | ||
| Q3 24 | $91.8M | $24.5M | ||
| Q2 24 | $107.0M | $12.4M | ||
| Q1 24 | $-125.2M | $20.2M |
| Q4 25 | — | $11.6M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $-4.2M | ||
| Q1 25 | — | $27.6M | ||
| Q4 24 | — | $-6.9M | ||
| Q3 24 | — | $18.0M | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | — | $9.8M |
| Q4 25 | — | 3.4% | ||
| Q3 25 | — | 2.2% | ||
| Q2 25 | — | -1.3% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | — | 5.6% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 2.4% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 2.9% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | 3.39× | 1.86× | ||
| Q3 25 | 1.91× | 1.32× | ||
| Q2 25 | 3.49× | 0.25× | ||
| Q1 25 | -5.66× | 2.60× | ||
| Q4 24 | 4.36× | 0.27× | ||
| Q3 24 | 4.72× | 2.72× | ||
| Q2 24 | — | 1.35× | ||
| Q1 24 | -31.03× | 2.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
